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Figure 4. Immunohistochemical staining after 14d in culture.
Conclusions: The microfabrication and collagen soft-lithography tech-
niques combined with crosslinking allowed high ﬁdelity formation of micro
sized channels on collagen membranes down to the smallest channel
designed (25 μm). The channels supported the viability of MSCs, while
selective cell attachment was ensured by the Pluronic treatment. Alignment
of MSCs along the length of the 25-100 μm channels and alignment of
collagen type II along the contours of the cell membrane within these
channels show the ability of these channels to inﬂuence cellular orientation,
which can lead to the alignment of ECM. To determine if the produced ECM
exhibits enhanced mechanical properties, mechanical testing comparing
oriented and random ECM produced in this system will be conducted in
future studies.
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Purpose: Although cell transplantation therapy using mesenchymal stem
cells (MSCs) is considered as a prominent strategy, one of the major prob-
lem is the limited proliferative activity. Recently, induced pluripotent stem
(iPS) cell line was developed as an alternative way due to their potential
proliferating inﬁnitely. However, the method to induce lineage-restricted
differentiation has not been well examined.
Methods: iPS cells were maintained on mouse embryonic ﬁbroblast feeder
layers. To induce mesenchymal cells, we used embryoid body (EB) forma-
tion followed by culture on gelatin-coated plates. We further introduced
micromass culture system to induce chondrocytes.
Results: The cultured adherent cells maintained multiple differentiation
properties to osteoblast, adipocyteand chondrocyte. (A) Alizarin red stain-
ing showed calcium deposition in osteoblast differentiation culture at day
10 of differentiation, and (B) oil red-O staining showed lipid accumulation
in adipocyte differentiation culture at day 10 of differentiation. (C) His-
tological and immunoﬂuorescent characterization of chondrocyte obtained
by pellet culture of the cultured adherent cells. They also possessed chon-
drogenic property, including Sox-9, aggrecan and type 2 collagen mRNA
expressions.
Conclusions: These results demonstrate the property of iPS cells as an
alternative candidate for treatment of cartilage degradation.
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Purpose: Osteoarthritis (OA) is one of the most frequent musculoskeletal
disorders and represents the main indication for total joint Arthroplasty.
Multipotent mesenchymal stromal cells (MSCs) can be easily isolated and
culture expanded from bone marrow aspirates and provide an excellent
source of progenitor cells. To assess whether advanced-stage OA affects
MSCs’ suitability for musculoskeletal regenerative therapy we compared
proliferation and differentiation potential as well as surface marker expres-
sion patterns of MSCs from osteoarthritic versus healthy donors.
Methods: MSCs were isolated from bone marrow aspirates (50 cc each)
obtained from the pelvic compartment of n=14 advanced-stage idiopathic
hip osteoarthritic (Kellgren and Lawrence grade 3 or 4, mean age 67±6
years) and n=15 age-matched (61±4 years) healthy donors by Ficoll
gradient-separation and plastic adherence. OA was objectiﬁed radiologi-
cally (only OA group) and by use of algofunctional indices (i.e. Western
Ontario McMaster Universities OA index, Harris Hip Score, EuroQol-5D).
MSCs were cultured in basic (DMEM, 10% fetal calf serum), osteogenic,
adipogenic, or chondrogenic medium for up to 21 days. For all assays
low-passage (<3) MSC populations were used. Proliferation was assessed
by total DNA quantiﬁcation, FACS analysis and CFU-F assay. Differentiation
was assessed immunocytologically, by cell-speciﬁc alkaline phosphatase
(ALP) activity assay, and by osteogenic (Runx-2, ALP, BSP2), chondrogenic
(Sox9, ColIIa, ColX), and adipogenic (PPARγ, FABP4) quantitative marker
gene real-time RT-PCR analysis. For expression analysis of selected MSC-
speciﬁc surface markers mean ﬂuorescence intensities and percentages of
positive cells were determined using a BD LSRII ﬂow cytometer. Overall
statistical signiﬁcance was deﬁned as p<0.05 (two-sided) based on all
pairwise comparisons. The study was approved by the local institutinal
review board (protocol #EK203082008).
Results: Algofunctional scores of osteoarthritic donors were lower com-
pared to healthy donors (p<0.0001). No signiﬁcant intergroup differences
were observed concerning the proliferation potential, cell-speciﬁc ALP
activity and adipogenic and osteogenic differentiation marker gene ex-
pression. Interestingly SOX9 gene expression levels were increased in
MSCs from OA patients after 14 day cultivation in chondrogenic medium
compared to MSCs from healthy donors (p<0.01). Expression levels of
CD73, CD90, and STRO-1 were elevated in respect of the negative control
cellular surface antigens CD14, CD34, and CD45 in MSCs derived from
both osteoarthritic and healthy donors (p<0.0001). Notable, MSCs from OA
patients showed decreased levels of CD166 expression compared to cells
from healthy donors (p<0.05).
Conclusions: The regenerative potential and surface marker patterns of
MSCs from osteoarthritic donors are comparable to MSCs from healthy
donors. However, the observed reduced CD166 expression levels as well
as the increased Sox9 gene expression levels in OA-MSCs warrants further
investigation. These data will help to facilitate the application of autologous
cell-based strategies for musculoskeletal tissue regeneration.
